EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Novel allosteric glutaminase inhibitors with macrocyclic structure activity relationship analysis (part 2)

Eun Ji Lee, Jiyoon Jang, Rajath Cyriac, Mi Ran Yun, Yeongju Kwon, Myoung Eun Jung, Gildon Choi, Chong Hak Chae, Byoung Chul Cho, Kwangho Lee

Bulletin of the Korean Chemical Society · 2024-07 · 45 (7) · 639-644

DOI: 10.1002/bkcs.12883 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bulletin of the Korean Chemical Society, online erschienen am 04.07.2024. Verfasst von Eun Ji Lee und 9 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Korea Drug Development Fund, Ministry of Science and ICT, South Korea, Korea Research Institute of Chemical Technology.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glutamine‐addicted cancer metabolism is recently recognized as novel cancer target especially for KRAS and KEAP1 co‐occurring mutations. To identify more drug‐like GLS inhibitors, we report the amides in the wing macrocycles for GLS inhibition with unique SAR analysis. Although the amidotriazoles (amides in the wing) are in general less potent than those of acylaminothiadiazole analogs (reverse amides in the wing), macrocycle 4, 5, and 7 are selected as a potent macrocyclic GLS inhibitor in both biochemical and cell viability assays. Selected molecules result in partial reduction in intracellular glutamate levels in LR (LDK378‐resistant) cells which is consistent to their cells viability result. Finally, selected compounds reduce the growth of A549 and H460 cells which have co‐occurring mutations including KRAS and KEAP1. The putative binding mode of macrocycle 4 is also suggested using a molecular docking model.

Förderung

  • Korea Drug Development Fund
  • Ministry of Science and ICT, South Korea
  • Korea Research Institute of Chemical Technology

Zitieren

APA

Lee, E. J., Jang, J., Cyriac, R., Yun, M. R., Kwon, Y., Jung, M. E., Choi, G., Chae, C. H., Cho, B. C., & Lee, K. (2024). Novel allosteric glutaminase inhibitors with macrocyclic structure activity relationship analysis (part 2). Bulletin of the Korean Chemical Society, 45(7), 639-644. https://doi.org/10.1002/bkcs.12883

Vancouver

Lee EJ, Jang J, Cyriac R, Yun MR, Kwon Y, Jung ME, et al. Novel allosteric glutaminase inhibitors with macrocyclic structure activity relationship analysis (part 2). Bulletin of the Korean Chemical Society. 2024;45(7):639-644. doi:10.1002/bkcs.12883

BibTeX
@article{Lee2024,
  author = {Lee, Eun Ji and Jang, Jiyoon and Cyriac, Rajath and Yun, Mi Ran and Kwon, Yeongju and Jung, Myoung Eun and Choi, Gildon and Chae, Chong Hak and Cho, Byoung Chul and Lee, Kwangho},
  title = {Novel allosteric glutaminase inhibitors with macrocyclic structure activity relationship analysis (part 2)},
  journal = {Bulletin of the Korean Chemical Society},
  year = {2024},
  volume = {45},
  number = {7},
  pages = {639--644},
  doi = {10.1002/bkcs.12883}
}
Kostenlos starten →